Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Coherus Prepares To Wave Goodbye To Udenyca – And 30% Of Its Staff
Final Annual Results Before Transfer Of Pegfilgrastim Franchise
Mar 13 2025
•
By
Dave Wallace
Coherus is losing 30% of its 225 employees
(Shutterstock)
More from Strategy
More from Products